Long-term effects of androgen deprivation therapy in prostate cancer patients.
about
The effects of testosterone deprivation and supplementation on proteasomal and autophagy activity in the skeletal muscle of the male mouse: differential effects on high-androgen responder and low-androgen responder muscle groupsOptimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk nonmetastatic prostate cancer: A systematic review and metaanalysisAdverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complicationsAndrogenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic reviewMuscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapyQuality of life issues in men undergoing androgen deprivation therapy: a reviewThe Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trialA mathematical investigation of the multiple pathways to recurrent prostate cancer: comparison with experimental dataA phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.Cardiac and cognitive effects of androgen deprivation therapy: are they real?High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.Expression of androgen receptor target genes in skeletal muscle.Intervening on the side effects of hormone-dependent cancer treatment: the role of strength training.NCCN Task Force Report: Bone Health in Cancer Care.A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseManagement of complications of androgen deprivation therapy in the older man.Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.Biochemical markers of bone turnover and clinical outcomes in men with prostate cancerThe effects of testosterone deficiency on male sexual function.Gonadal status and physical performance in older men.Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.What do prostate cancer patients die of?Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial.Cardiometabolic and skeletal risk factors in black men with prostate cancer starting androgen deprivation therapy.The Exercising Together project: design and recruitment for a randomized, controlled trial to determine the benefits of partnered strength training for couples coping with prostate cancer.Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.Patterns and correlates of grip strength change with age in Afro-Caribbean men.A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy.The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy.Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.Pharmacologically induced hypogonadism and sexual function in healthy young women and menFee-for-service cancer rehabilitation programs improve health-related quality of lifeAndrogen-Deprivation Therapy and Cardiovascular Disease Risk - The Role of Exercise in Prostate Cancer Treatment.Are declining testosterone levels a major risk factor for ill-health in aging men?Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study.Exercise therapy across the prostate cancer continuum.
P2860
Q24596896-E579F7F4-1C5D-439E-B615-6EB48FBA3AB5Q26801000-F7984A6F-9F96-447F-86A8-3D76740C95EDQ26852930-42462A5C-C26B-4947-822B-430A9D1FA191Q26863665-839A881D-55CC-4C9B-B9D6-5A54D53F6494Q26864943-368DCB4E-9996-40FF-BCE3-51EA3E4D8F2AQ27002887-28EC6F91-E88B-4F1E-9796-54707ABAFABDQ30587975-D7433BBC-8C08-4CB8-9562-57155EB3DDB0Q30983127-8B15E470-1A99-4DC5-910D-260D6F39BA4EQ33475929-2F843959-EDB2-4379-8414-E5B9235F3835Q33677118-C8350487-D1FE-42EA-9F5C-999EA667A692Q34111628-9F7FD0AD-64B1-4CB5-907F-7936F11FEE43Q34420098-5440E051-AE0F-400F-AF2D-6E0F62E3CA4DQ34433210-FD0C4267-057C-443E-9F2C-AD333D1E9BDBQ34557490-EB6CDF98-21AB-4041-9FC7-52557582588EQ34617936-97D873AD-86BD-4559-A1A9-997D32208E0FQ34663266-296B23EF-03CB-4920-A187-33F43A5CF478Q34782101-E7182529-2348-4BCB-A1E3-341CA269A780Q34943307-16C5A084-55F7-4388-8A27-BEB55B89E958Q35022212-9253ABD9-B436-4F5D-B34A-4002B5337D4DQ35082988-FDE28B9F-4923-4D2B-B98A-5AD7FA7FBAD8Q35125421-A5153A1B-856E-4B70-B829-02CCDD314B5CQ35433102-1F74A448-9145-4CD9-B3CE-65C8B143D446Q35584421-BFFD4D96-165C-4A47-B5B3-1E6ED0B8CE03Q35610624-3A74BE05-323B-4779-858A-1D9CE63227D2Q35614699-FC8AD182-2678-4224-8F5B-E19117C38379Q35713080-0B6C9889-DDEE-49A2-9546-D4D6640B338AQ35774987-22B8819E-E66F-436E-9935-E9B40B16C4E1Q35909632-7C18C74E-FCA2-4CD5-A543-7E0DC95551F7Q36467601-AC5FB54A-85B1-4DD7-AFBB-F69558528C06Q36575143-22BBCCDD-EA1A-4784-9190-BA02104B91AFQ36672192-54F66672-C351-49AC-A01C-21EC7080AAADQ36723162-B49C3398-01FF-4EA3-8B2F-20631CB3ED89Q36814324-9B55C542-146B-430F-8A85-B49CAD6AE0FFQ36981339-A76E5F73-E74A-4DB4-B86F-7B5928172C80Q37060552-8464713D-5E07-4F9C-91A7-B28CDCA8598CQ37152882-907F5FBE-9239-4084-923D-6DDC63FB42C9Q37263544-0E6C8186-68E8-45E1-9649-CEC88555A48CQ37335851-BC02048A-A721-4350-B5E1-BC0680408EA5Q37389651-DC42954E-EC6A-4D4A-B078-C9F5D8BDFC6CQ37410849-BE929EBC-92D1-41B0-9EAA-CDCB2F07101F
P2860
Long-term effects of androgen deprivation therapy in prostate cancer patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@en
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@nl
type
label
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@en
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@nl
prefLabel
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@en
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@nl
P2093
P2860
P1476
Long-term effects of androgen deprivation therapy in prostate cancer patients.
@en
P2093
Adrian S Dobs
Alice M Tang
Mario Eisenberger
Michael Carducci
Shehzad Basaria
Theodore DeWeese
P2860
P304
P356
10.1046/J.1365-2265.2002.01551.X
P577
2002-06-01T00:00:00Z